Patient Knowledge and Opinions of Human Papillomavirus Vaccination for Head and Neck Cancer Prevention
Dr. Daniel Faden, MD, Assistant Professor of Otolaryngology-Head and Neck Surgery, Harvard Medical School discusses his research on patient knowledge and opinions of human Papillomavirus vaccination for head and neck cancer prevention which was presented at the 2022 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) annual meeting.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Daniel Faden, MD, Assistant Professor of Otolaryngology-Head and Neck Surgery, Harvard Medical School discusses his research on patient knowledge and opinions of human Papilloma…
- Key Point: Daniel Faden is a Head and Neck Surgical Oncologist and Translational Scientist.
- Key Point: He completed residency training in Otolaryngology– Head and Neck Surgery at UCSF followed by clinical fellowships at the University of Pittsburgh Medical Center in both Advanc…
- Key Point: His clinical practice focuses on head and neck and cranial base cancers with a particular interest and expertise in minimally invasive head and neck cancer surgery (TORS, TOLS, …
- Key Point: Prior to Boston, he was a Howard Hughes Medical Institute Research Scholar at the National Institutes of Health/ National Human Genome Research Institute and completed a Postdoc…
Dr. Daniel Faden is a Head and Neck Surgical Oncologist and Translational Scientist. He completed residency training in Otolaryngology– Head and Neck Surgery at UCSF followed by clinical fellowships at the University of Pittsburgh Medical Center in both Advanced Head and Neck Oncologic Surgery and Cranial Base Surgery. His clinical practice focuses on head and neck and cranial base cancers with a particular interest and expertise in minimally invasive head and neck cancer surgery (TORS, TOLS, endoscopic cranial base surgery). Prior to Boston, he was a Howard Hughes Medical Institute Research Scholar at the National Institutes of Health/ National Human Genome Research Institute and completed a Postdoctoral Research Fellowship at the University of Pittsburgh under Robert Ferris, MD, PhD.
Dr. Daniel Faden’s research examines how acquired genomic alterations and viral infection affect head and neck cancer initiation, growth, and response to treatment. As a practicing head and neck cancer surgeon, the overarching goal of Dr. Faden’s research is to translate findings from the laboratory to clinical advancements that address the most pressing problems faced by head and neck cancer patients
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



